Man Group PLC Compugen LTD Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.58 - $1.2 $473,632 - $979,929	-816,608 Reduced 89.77%	93,106 $67,000
Q3 2022 Nov 14, 2022	BUY	$0.66 - $2.32 $312,254 - $1.1 Million	473,113 Added 108.36%	909,714 $598,000
Q2 2022 Aug 15, 2022	BUY	$1.57 - $3.33 $474,020 - $1.01 Million	301,924 Added 224.18%	436,601 $808,000
Q1 2022 May 16, 2022	BUY	$2.76 - $4.64 $318,164 - $534,885	115,277 Added 594.21%	134,677 $434,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $79,346 - $138,904	19,400 New	19,400 $83,000

13.4M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $152M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.